Small doses of aripiprazole augmentation of antidepressant treatment: A report of 3 cases

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 10, Issue 3, 2008, Pages 252-253

  Terao, Takeshi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXAPINE; ARIPIPRAZOLE; FLUVOXAMINE; LITHIUM; MAPROTILINE; MIANSERIN; PAROXETINE; SERTRALINE; TRAZODONE;

ADULT; ANAMNESIS; CASE REPORT; DRUG POTENTIATION; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; LETTER; MAJOR DEPRESSION; MALE; RELAPSE; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 45849146499     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/pcc.v10n0312e     Document Type: Letter

References (5)

1. Pae CU, Patkar AA, Jun TY, et al. Aripiprazole augmentation for treatment of patients with inadequate antidepressants response. Depress Anxiety 2006;24:522-526
2. Papakostas GI, Petersen TJ, Kinrys G, et al. Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder. J Clin Psychiatry 2005(Oct);66(10):1326-1330
3. Patkar AA, Peindl K, Mago R, et al. An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression. Prim Care Companion J Clin Psychiatry 2006;8(2):82-87
4. Berman RM, Marcus RN, Swanink R, et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2007(June);68(6):843-853
5. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62